1.The Preservation of Left Gastric Atery in Laparoscopy-Assisted Subtotal Gastrectomy with Splenectomy of Stomach Cancer.
Sang Rim LEE ; Jong Min PARK ; Sang Uk HAN ; Young Kwan CHO
Journal of the Korean Gastric Cancer Association 2007;7(1):42-46
Usually in the subtotal gastrectomy, the left and the right gastric arteries, as well as the left and the right gastroepiploic arteries are ligated. Thus, to avoid a blue stomach surgeons preserve the spleen and the short gastric arteries. When a radical subtotal gastrectomy with splenectomy is performed, meticulous caution is necessary; otherwise, the subtotal gastrectomy might have to be changed to a total gastrectomy to prevent a blue stomach. We report the case of a 67-year-old woman who had distal stomach cancer with a splenic solitary mass, for which splenic meatastasis could be excluded. We planned and performed a laparoscopy-assisted radical subtotal gastrectomy with splenectomy as the diagnostic and therapeutic option. In this case, to avoid a remnant stomach infarction or total gastrectomy we saved the left gastric artery and vein with clearing perivascular soft tissue, lymphatics, and lymph nodes. Thus the radical therapeutic goal was reached, and serious complications were avoided.
Aged
;
Arteries
;
Female
;
Gastrectomy*
;
Gastric Stump
;
Gastroepiploic Artery
;
Humans
;
Infarction
;
Lymph Nodes
;
Spleen
;
Splenectomy*
;
Stomach Neoplasms*
;
Stomach*
;
Veins
2.Gastric Adenocarcinoma in Patient with Pernicious Anemia: A Case Report.
Byung Soo KIM ; Jong Won KIM ; In Kyu LEE ; Dong Chul KIM ; Woo Ho KIM ; Hyuk Joon LEE ; Han Kwang YANG
Journal of the Korean Gastric Cancer Association 2007;7(1):38-41
Increased risk of gastric cancer has been reported in patients with chronic atrophic gastritis that develops in conjunction with pernicious anemia. We report here a case of a gastric adenocarcinoma associated with pernicious anemia. A 40-year-old female patient had been diagnosed with anemia 6 years earlier at a local hospital. One month ago, she visited our hospital for aggravated dizziness and newly developed epigastric soreness. Her blood hemoglobin level was 4.2 g/dl, and a gastroscopic work-up for anemia discovered a 2.5-cm-sized, slightly elevated mucosal lesion at the anterior wall of the high body in the stomach. The biopsy of this lesion revealed a moderately-differentiated adenocarcinoma. She underwent a total gastrectomy with a Roux en Y esophagojejunostomy with D2 lymph node dissection. The final stage of the gastric carcinoma was identified as T1N0M0. Based on this experience, we recommend that a follow-up gastroscopy be performed in patients with pernicious anemia with atrophic gastritis because of the increased risk of gastric cancer in patients with pernicious anemia.
Adenocarcinoma*
;
Adult
;
Anemia
;
Anemia, Pernicious*
;
Biopsy
;
Dizziness
;
Female
;
Gastrectomy
;
Gastritis, Atrophic
;
Gastroscopy
;
Humans
;
Lymph Node Excision
;
Stomach
;
Stomach Neoplasms
3.Complications Following and Supplementary Procedures for a Pancreas-preserving Total Gastrectomy.
Moon Soo LEE ; Gil Ho KANG ; Gyu Seok CHO ; Yong Jin KIM ; Sung Yong KIM ; Moo Jun BAEK ; Chang Ho KIM ; Moo Sik CHO
Journal of the Korean Gastric Cancer Association 2007;7(1):31-37
PURPOSE: A pancreas-preserving total gastrectomy (PPTG) was introduced to decrease the postoperative complications due to pancreatic resection. However, some complications, such as leakage of pancreatic juice, are still reported. Thus, the purpose of this study was to propose a supplementary procedure based on the results of treatment for gastric cancer at our hospital. MATERIALS AND METHODS: From Jan. 1997 to Dec. 2004, the cases of 141 patients who underwent a PPTG for gastric cancer were reviewed retrospectively. The patients were divided into Group A (38 cases), patients who were treated using a conventional PPTG, and Group B (103 cases), patients who were treated using a new and improved PPTG. Their postoperative complications were compared. RESULTS: No statistically significant differences in clinicopathologic data were noted between the two groups. The comparison of complications showed for groups A and B, respectively, 4 and 0 cases of pancreatic fistula, 1 and 0 cases of intraabdominal abscess, 2 and 0 cases of intraoperative pancreatic necrosis, and 2 and 2 cases of minor leakage. The difference in the prevalence of complications between the two groups was statistically significant (P=0.0001). CONCLUSION: In order to reduce the risk of PPTG-related complications, we used vascular clamps to observe the necrosis of the pancreatic tail before dividing the splenic artery, and this method resulted in a significant decrease in postoperative complications. Thus, we conclude that our use of vascular clamps in a PPTG is a simple and useful method for preventing postoperative complications.
Abscess
;
Gastrectomy*
;
Humans
;
Necrosis
;
Pancreatic Fistula
;
Pancreatic Juice
;
Postoperative Complications
;
Prevalence
;
Retrospective Studies
;
Splenic Artery
;
Stomach Neoplasms
4.Clinicopathologic Characteristics according to the Type of Recurrence in Curatively-resected Gastric Cancer Patients.
Journal of the Korean Gastric Cancer Association 2007;7(1):23-30
PURPOSE: Evaluating the clinicopathologic characteristics of recurred gastric cancer is essential for early detection of the recurrence and for better clinical outcome. The aim of this study was to establish the patterns of the recurrence, the timing of the recurrence, and the clinical result after recurrence according to the clinicopathologic characteristics of gastric cancer. MATERIALS AND METHODS: From June 1992 to December 2005, of the 1338 gastric cancer patients who underwent a curative gastric resection, 241 patients who recurred during the follow-up period were selected and their cases were analyzed. The clinicopathologic characteristics of the patients, the time to recurrence after operation and survival were determined retrospectively according to the type of recurrence. RESULTS: For the recurrent group, the numbers of total gastrectomies, advanced stages, lymphatic and/or venous infiltrations, whole stomach cancer cases, large tumors, undifferentiated tumors, and Borrmann type 4 tumors were higher than they were for the non-recurrent group, and the differences were statistically significant. When the recurrence types were classified as peritoneal seeding, hematogenous recurrence, and locoregional recurrence, independent risk factors were female gender, stage III, upper third, and whlole stomach cancer, and undifferentiated-type, diffuse-type, and Borrmann type 4 tumors for peritoneal seeding; early gastric cancer, stage I for hematogenous recurrence; and Borrmann type 1, 2, and 3 tumors for locoregional recurrence. Survival duration after detection of the recurrence was shorter for peritoneal seeding than for hematogenous or locoregional recurrence (7.0 months vs. 9.5 months and 12.5 months). CONCLUSION: For early detection of the recurrence after curative surgery for gastric cancer, it is important to recognize that the high risk factors for recurrence vary with the clinicopathologic data for the patients.
Female
;
Follow-Up Studies
;
Gastrectomy
;
Humans
;
Recurrence*
;
Retrospective Studies
;
Risk Factors
;
Stomach Neoplasms*
5.Comparison of the Results in Gastric Carcinoma Patients undergoing Billroth I and Billroth II Gastrectomiesy.
Sung Geun KIM ; Young Kyun KIM ; Youn Jung HEO ; Kyo Young SONG ; Jin Jo KIM ; Hyung Min JIN ; Wook KIM ; Cho Hyun PARK ; Seung Man PARK ; Keun Woo LIM ; Seung Nam KIM ; Hae Myung JEON
Journal of the Korean Gastric Cancer Association 2007;7(1):16-22
PURPOSE: The proper reconstruction technique to use after a distal subtotal gastrectomy for a gastric carcinoma, there has been a subject for debated what is the proper reconstruction technique. The aim of this study was to compare the gastric- emptying time and the quality of life following both B-I and B-II reconstructions after a distal gastrectomy for a gastric adenocarcinoma. MATERIALS AND METHODS: We studied 122 patients who had undergone a distal gastrectomy for a gastric adenocarcinoma between June 1999 and July 2002 at our hospital. 51 patients underwent B-I group, and 71 patients underwent B-II group. To evaluate the gastric-emptying time, we analyzed the T1/2 time by means of radionuclide scintigraphy using a gamma camera after ingestion of an (99m)Tc-tin-colloid steamed egg. The nutritional status was measured by the weight change. Postgastrectomy syndrome was evaluated using an abdominal symptoms survey. Dumping syndrome was measured using the Sigstad dumping score. RESULTS: The gastric-emptying time was somewhat delayed in the B-I group after a 6 month period, but there was no difference after 12 months between the two groups. There was less weight loss in the B-I group than in the B-II group (P=0.023). Fewer abdominal symptoms were occurred in the B-I group than in the B-II group. Dumping syndrome occurred less frequently in the B-I group than in the B-II group (P=0.013). CONCLUSION: In our study, the Billroth I reconstruction led to less weight loss, a better nutritional status, and a better quality of life than the Billroth II reconstruction. We concluded that after a distal subtotal gastrectomy, the Billroth I reconstruction would be considered when the procedure is oncologically suitable.
Adenocarcinoma
;
Dumping Syndrome
;
Eating
;
Gamma Cameras
;
Gastrectomy
;
Gastroenterostomy*
;
Humans
;
Nutritional Status
;
Ovum
;
Postgastrectomy Syndromes
;
Quality of Life
;
Radionuclide Imaging
;
Steam
;
Stomach Neoplasms
;
Weight Loss
6.DNMT3b Promoter Polymorphism and Risk of Gastric Cancer in the Korean Population.
Sung Geun KIM ; Hun JUNG ; Sin Sun KIM ; Kyung Hwa JEON ; Kyo Young SONG ; Jin Jo KIM ; Hyung Min JIN ; Wook KIM ; Cho Hyun PARK ; Seung Man PARK ; Keun Woo LIM ; Seung Nam KIM ; Hae Myung JEON
Journal of the Korean Gastric Cancer Association 2007;7(1):9-15
PURPOSE: DNA methylation is an important epigenetic factor in tumorigenesis. We hypothesized that polymorphism of the promoter of the DNA methyltransferase 3b (DNMT3b) genes, which are responsible for regulating the methylation status of tumor suppressor genes, are associated with increased risk of gastric cancer. MATERIALS AND METHODS: In this hospital-based case-control study, to determine the role of this polymorphism of the promoter of DNA methyltransferase 3b (DNMT3b) genes in gastric cancer, we genotyped 176 cases and 70 control subjects. To determine the genotype, we used a polymerase chain reaction restriction fragment length polymorphism assay. We compared alleles and genotypes between the two groups and revealed an association of DNMT3b promoter polymorphism with increased risk of gastric cancer in the Korean population. RESULTS: Genotype frequencies were 14.8% (Cytosine-Cytosine), 71.6% (Cytosine-Thymine), and 13.6% (Thymine- Thymine) in the case patients and 40.0% (Cytosine-Cytosine), 42.9% (Cytosine-Thymine), and 17.1% (Thymine-Thymine) in the control subjects, respectively. Compared with CC homozygotes, CT heterozygotes had a 4.523-fold increased risk (OR, 2.13; 95% CI, 2.324~8.803), and the TT homozygotes had a 2.154-fold elevated risk (OR, 1.42; 95% CI, 0.899~5.165). For the T variant genotype (CT+TT), there was a 3.846-fold increased risk (OR, 1.88; 95% CI, 2.040~7.251). However, no significance was observed in the genotype distributions of both polymorphisms according to histopathology, stage of stomach cancer. The Ssame results were observed with Helicobacter infection. CONCLUSION: DNMT3b promoter polymorphism, especially the T variant genotype, is associated significantly with thean increased risk of gastric cancer.
Alleles
;
Carcinogenesis
;
Case-Control Studies
;
DNA
;
DNA Methylation
;
Epigenomics
;
Genes, Tumor Suppressor
;
Genotype
;
Helicobacter Infections
;
Heterozygote
;
Homozygote
;
Humans
;
Methylation
;
Polymerase Chain Reaction
;
Polymorphism, Restriction Fragment Length
;
Stomach Neoplasms*
7.Comparative Analysis of Laparoscopy-assisted Gastrectomy versus Open Gastrectomy.
Jung Taek LIM ; Byung Sik KIM ; Oh JEONG ; Ji Hoon KIM ; Jeong Hwan YOOK ; Sung Tae OH ; Kun Choon PARK
Journal of the Korean Gastric Cancer Association 2007;7(1):1-8
PURPOSE: There has been increased the number of early gastric cancer and laparoscopy-assisted gastrectomy (LAG), due to early detection through mass screening program. We started the LAG in April 2004 and performed 119 cases of gastric cancer in 2005, so we report a surgical outcome compared with that of open gastrectomy (OG). MATERIALS AND METHODS: 119 patients underwent LAG in 2005, and for open group, 126 patiens of early gastric cancer were selected sequentially from January 2005 to March 2005. We compared clinicopathologic characteristics, postoperative courses and complications between two groups. RESULTS: There was no significant difference between age, a length of hospital stay, distal resection margin and a number of retrived lymph nodes. The operation time was longer in LAG group (239.2 vs 123.3 mins, P < 0.001) and a diet progression was faster in LAG group (first flatus: 3.05 vs 3.70 days, SOW: 2.86 vs 3.22 days, liquid diet: 3.87 vs 4.19 days ,soft diet: 4.84 vs 5.26 days, P < 0.001). But there was no difference statistically in postoperative discharge date (7.73 vs 8.25 days, P=0.229). The additional requirement of analgesic injection was less frequent in LAG group (2.97 vs 4.92 times, P < 0.001). The harvested lymph nodes were similar in both groups (23.9 vs 23.1, P=0.563). A complication rate was lower in LAG group (4.9% vs 9.5%), but there was no statistical significance (P=0.179). There was no mortality in both groups and no conversion to open gastrectomy in the LAG group. CONCLUSION: LAG can be performed safely and accepted in view of curative procedure in treatment of early gastric cancer. But we need the follow up of long-term period to evaluate the survival rate and recurrence, and a prospective randomized controlled study should be done to establish that LAG will be a standard operation for early gastric cancer.
Diet
;
Flatulence
;
Follow-Up Studies
;
Gastrectomy*
;
Humans
;
Length of Stay
;
Lymph Nodes
;
Mass Screening
;
Mortality
;
Recurrence
;
Stomach Neoplasms
;
Survival Rate
8.Surgery for Cancer Arising at an Anastomotic Site after Radical Total Gastrctomy.
Ho Young YOON ; Sang Hoon LEE ; Choong Bai KIM
Journal of the Korean Gastric Cancer Association 2007;7(3):174-179
The survival of patients with gastric cancer is improved by early diagnosis and surgical treatment. However, there is no established treatment for locally recurrent cancer or cancer arising at an anastomotic site after total gastrectomy; further, most surgeons are reluctant to resect this type of cancer because of frequent systemic metastasis and there are few competent surgeons who have the skill to perform such an operation. We have experienced recurrent cancer at an anastomotic site after total gastrectomy: one patient had recurrent cancer and two patients had metachronous cancer. All these patients were operated on and the patients were discharged without any complications. All of them are alive at the time of this report. In some cases, good results could be expected for operating on recurrent cancer of an anastomotic site after previous total gastrectomy. So, we present here our experience along with a review of literatures.
Early Diagnosis
;
Gastrectomy
;
Humans
;
Neoplasm Metastasis
;
Stomach Neoplasms
9.The Immunological Effect of Mistletoe Extract on Gastric Cancer Patients.
Sung Woo YANG ; Dong Gue SHIN ; Il Myung KIM ; Seong Min YOON ; Yong Jik LEE ; Su Hak HEO ; Tae Hee KIM
Journal of the Korean Gastric Cancer Association 2007;7(3):167-173
PURPOSE: Mistletoe (Viscum album L.) extract is one of the most widely used agents in alternative cancer therapeutic regimens in Europe. This study was conducted to determine the effect of mistletoe extract on immune function in gastric cancer patients. MATERIALS AND METHODS: Ten patients that had undergone a curative gastrectomy were enrolled in the prospective study. ABNOBAviscum Q(R) was injected subcutaneously three times a week from postoperative-day 7 to week 16 with an increasing dose. All of the patients simultaneously received chemotheraphy with mitomycin, oral 5-FU and a cisplatin regimen. The WBC count, differential count, lymphocyte/WBC ratio and the level of cytokines (IL-1beta, IL-2, IL-6, IFN-gamma, TNF-alpha) were checked in the peripheral blood preoperatively, at postoperative week 8 and at postoperative week 16. RESULTS: The WBC and neutrophil counts significantly decreased after treatment on week 8 and week 16 (P=0.001), but the total eosinophil count was slightly increased (P=0.15). The total lymphocyte count also decreased during treatment but the lymphocyte/WBC ratio was slightly increased without statistical significance (P=0.91). The cytokine levels did not significantly change during treatment. CONCLUSION: It is somewhat difficult to determine the direct effect of mistletoe therapy on immune function as the effect may be compromised by the concurrent chemotherapy. It can be assumed that the slightly increased lymphocyte/WBC ratio and eosinophil count may be a result of the immunomodulatory effect of the mistletoe extract.
Cisplatin
;
Cytokines
;
Drug Therapy
;
Eosinophils
;
Europe
;
Fluorouracil
;
Gastrectomy
;
Humans
;
Interleukin-2
;
Interleukin-6
;
Lymphocyte Count
;
Mistletoe*
;
Mitomycin
;
Neutrophils
;
Prospective Studies
;
Stomach Neoplasms*
10.The Results of the ATP Based Chemotherapy Response Assay in Gastric Cancer Tissues.
Journal of the Korean Gastric Cancer Association 2007;7(3):160-166
PURPOSE: Recently, chemosensitivity tests have become widely used for the selection of effective drugs in gastric cancer patients. In this study, a chemosensitivity test was performed to select agents to increase the effectiveness of adjuvant chemotherapy. MATERIALS AND METHODS: Chemosensitivity testing was performed in 81 gastric cancer patients that received a gastrectomy at the Yeungnam University Hospital. An ATP (adenosine triphosphate) based chemotherapy response assay was used. Clinicopatholgical factors such as sex, age, expression of tumor markers (CEA and CA19-9 levels), location of the tumor, morphology of advanced cancer, histological type, cell differentiation, depth of invasion, Lauren classification, Ming classification, lymphatic invasion, vascular invasion, neural invasion, lymph node metastasis and TNM stage were used to correlate the chemosensitivity and clinicopathological factors. RESULTS: The most effective antitumor agents in gastric cancer patients were (in order of effectiveness) 5-FU, Epirubicin, Irinotecan and Oxaliplatin in our series. The chemosensitivity test showed a significant difference in susceptibility according to clinicopathological factors. CONCLUSION: Further studies on multidrug therapy are needed to evaluate synergistic effects of drugs. Therefore, for effective chemotherapy, it is more efficacious to select a chemosensitive drug than continue to use the same drug regimen.
Adenosine Triphosphate*
;
Antineoplastic Agents
;
Cell Differentiation
;
Chemotherapy, Adjuvant
;
Classification
;
Drug Therapy*
;
Epirubicin
;
Fluorouracil
;
Gastrectomy
;
Humans
;
Lymph Nodes
;
Neoplasm Metastasis
;
Stomach Neoplasms*
;
Biomarkers, Tumor